TMTT Today #12 – July 2024

• Explore evidence from TRISCEND study and TRISCEND II pivotal trial demonstrating that the EVOQUE system is a promising option for patients with symptomatic severe TR.
• Find out about the challenges of treating TR and recent advances in transcatheter tricuspid valve intervention.
• Discover insights into the development of the world’s first transfemoral tricuspid valve replacement system.*
• Read tips and tricks from a series of 3 cases with the EVOQUE and PASCAL Precision systems
  ^{*First-of-its kind device commercially available (in the EU).}